Karen Bush

George Washington University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

74h-index30.4kcitations311works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(199), Antibiotics Pharmacokinetics and Efficacy(102), Antimicrobial Resistance in Staphylococcus(53), Antibiotic Use and Resistance(48), Pharmaceutical and Antibiotic Environmental Impacts(35)

Publications311 total

Triazole Resistance and Misidentification of <i>Aspergillus tubingensis</i> in Southern California
JAMA Network Open·2025· 1 citedOpen Access
SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering
Antimicrobial Agents and Chemotherapy·2025· 5 citedOpen Access
Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the <scp>PARC</scp> Cohort
Arthritis Care & Research·2025· 2 citedOpen Access
Past, present, and future perspectives on aztreonam and avibactam
Expert Review of Anti-infective Therapy·2025· 6 cited
Identification of Conserved Eukaryotic Gene Products in Novel Mycobacteriophage
Journal of Purdue Undergraduate Research·2024Open Access
AB0477 EXPERIENCES AND PERSPECTIVES OF PATIENTS WITH PSORIATIC ARTHRITIS PARTICIPATING IN A RANDOMIZED CONTROLLED TRIAL OF DIETARY INTERVENTIONS
Annals of the Rheumatic Diseases·2024
Contributors
Elsevier eBooks·2024
Commentary on The antibiotic explosion by H. Boyd Woodruff and Richard W. Burg
Elsevier eBooks·2024
Antibacterial Agents
ClinMicroNow·2023
Antibacterial Agents
ClinMicroNow·2023
AB1122 GUSELKUMAB VS GOLIMUMAB IN PSA TNFI-INADEQUATE RESPONDERS (EVOLUTION): FORMULATING A PRAGMATIC PHASE 3B RANDOMIZED TRIAL
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
Classification for β-lactamases: historical perspectives
Expert Review of Anti-infective Therapy·2023· 31 cited
A Tribute to George A. Jacoby
Antimicrobial Agents and Chemotherapy·2022Open Access
Consensus on β-Lactamase Nomenclature
Antimicrobial Agents and Chemotherapy·2022· 31 citedOpen Access
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates
Diagnostic Microbiology and Infectious Disease·2022· 14 cited
Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria
Antimicrobial Agents and Chemotherapy·2021· 1 citedOpen Access
Critical analysis of antibacterial agents in clinical development
Nature Reviews Microbiology·2020· 357 citedOpen Access
Epidemiology of β-Lactamase-Producing Pathogens
Clinical Microbiology Reviews·2020· 845 citedOpen Access
A Standard Numbering Scheme for Class C β-Lactamases
Antimicrobial Agents and Chemotherapy·2019· 78 citedOpen Access
Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance
Journal of Antimicrobial Chemotherapy·2019· 35 cited
page 1 of 16Next →

Frequent Co-authors

Anne Marie Queenan(6), George A. Jacoby(5), Patricia A. Bradford(5), B A Rasmussen(5), John P. Quinn(4), Mark J. Macielag(3), R. B. Sykes(3), Hesna Yigit(2), Antonio Doménech‐Sánchez(2), James W. Biddle(2), Sebastián Albertí(2), Fred C. Tenover(2), Steven J. Projan(2), Darren Abbanat(2), D P Bonner(2), N H Georgopapadakou(2), Nelson L. ‘Shasha’ Jumbe(2), Arnold Louie(2), Robert Leary(2), Weiguo Liu(2)